4th Annual Corporate Compliance & Transparency in the Pharmaceutical Industry 2016

Key Topics

• Compliance challenges relating to data privacy
• The implementation of Disclosure Code and the first outcomes
• How to optimise interactions with HCPs and HCOs through a fully compliant and transparent strategy
• Fair Market Value and develop a consistent, simple and transparent method for your company
• How to establish an adequate investigation manual and procedures
• Compliance implications and concerns for merging corporate cultures
• How to analyse data and signs to identify compliance risks

Who should Attend

SVPs, CxOs, Global heads, VPs, Directors, Heads, Counsels and Officers from:

• Ethics/ Business Ethics
• Managers of: Pharma/ Biotech companies responsible for Compliance
• Regulatory Affairs
• Legal
• Governmental bodies
• Risk Monitoring etc. Representatives of Law firms
• Audit companies